Literature DB >> 2956289

Ischemic optic neuropathy secondary to intracarotid infusion of BCNU.

L Pickrell, V Purvin.   

Abstract

A 39-year-old man with a left parietal malignant glioma was treated with intracarotid infusion of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Five weeks after a second infusion, he developed inferior altitudinal visual field loss and pallid optic disc edema ipsilateral to the injection. Retinal vasculitis is a well-recognized complication of intra-arterial BCNU infusion. It is believed that this patient suffered a similar vasculopathy in the posterior ciliary artery circulation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2956289

Source DB:  PubMed          Journal:  J Clin Neuroophthalmol        ISSN: 0272-846X


  3 in total

1.  Revisiting intra-arterial drug delivery for treating brain diseases or is it "déjà-vu, all over again"?

Authors:  Shailendra Joshi; Jason A Ellis; Charles W Emala
Journal:  J Neuroanaesth Crit Care       Date:  2014-05

2.  Visual toxicity following intra-arterial chemotherapy with hydroxyethyl-CNU in patients with malignant gliomas. A prospective study with statistical analysis.

Authors:  G Defer; F Fauchon; M Schaison; J Chiras; P Brunet
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

Review 3.  Reassessing the Role of Intra-Arterial Drug Delivery for Glioblastoma Multiforme Treatment.

Authors:  Jason A Ellis; Matei Banu; Shaolie S Hossain; Rajinder Singh-Moon; Sean D Lavine; Jeffrey N Bruce; Shailendra Joshi
Journal:  J Drug Deliv       Date:  2015-12-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.